To prevent HIV infection, two times a year should be injected! Researchers claim that success has been found in clinical trials. Clinical trials have been conducted in South Africa and Uganda. The results of this study are promising. The World Health Organization is investigating the clinical trial’s claims of success. If the researchers’ claims are correct, this special injection may be approved for use in HIV treatment around the world. But experts say that more research is needed before that. If the research proves 100 percent successful, then this injection can be approved for use worldwide.
What does the new study claim?
According to South African researcher Linda-Gail Becker, young women can be completely protected from HIV infection if they take pre-exposure prophylaxis drug injections twice a year. In this clinical trial, injections of lenacavir given every 6 months were more protective than any other drug. Injections are more effective than tablets. So far, three pre-exposure prophylaxis drugs have been approved for the treatment of HIV. Two pills are approved along with an injection. However, researchers claim that the injection works much better than the pill.
HIV infection is highest in Africa:
Although HIV infection has spread all over the world, it has taken the worst form in Africa. For this reason, Africa has been chosen for the clinical trial. Clinical trials have been conducted at 3 sites in Uganda and 25 sites in South Africa. 5,000 people joined. A lenacapavir injection has been applied to their body. Researchers claim that they are healthy with this injection every 6 months.
